Lipid Mediators in Host–Pathogen Interactions during Leishmania Infection: Friends or Foes?

Read full text
Authors: Yasmin Monara Ferreira de Sousa Andrade, Darlaine Alves Silva, Tainá Larissa Pires Nascimento, Matheus Oliveira Sousa, Beatriz Lorrany Araújo Carvalho, Jonilson Berlink Lima, Valéria M. Borges, Théo Araújo-Santos
Cited by: 1
References: 103

Abstract

High Resolution Image Download MS PowerPoint Slide Lipid mediators can control the inflammatory response in infectious diseases, including leishmaniasis. However, these mediators may promote antagonistic roles in the Leishmania –host interaction depending on the species involved in the infection. Herein, we analyzed the role of mediators in the Leishmania –host interaction in the experimental and clinical context, aiming to identify the main cell types studied, as well as the main eicosanoids and their influence during the infection. The main lipid mediators studied were the eicosanoids LTB 4 and PGE 2, which are related to the inflammatory response in cutaneous and visceral leishmaniasis. In vitro models using macrophages and neutrophils infection reveal that LTB 4 plays a fundamental role in reducing the parasite load, while PGE 2 and PGF 2α suppress the immune response, favoring the survival of the parasite in the host. In the in vivo infection, PGE 2 is related to the visceralization process of the disease and the persistence of tegumentary lesions. An emerging role in pathophysiology has been pointed out for the mediators of the HETE class and for Resolvin D 1, which act favoring Leishmania infection and are associated with more severe cases of the disease. Thus, it can be concluded that lipid mediators play crucial roles in the Leishmania –host interaction, modulating the inflammatory response and disease progression. Studies exploring the contribution of intervention in the production of lipid mediators during the course of the disease are still needed.

Fields of Study & Subjects

Fatty Acid Research and Health Cancer Lipids and Metabolism Research on Leishmaniasis Studies

Publication details

Journal / source
ACS Infectious Diseases
Publisher
American Chemical Society (ACS)
Volume
12
Issue
6
Pages
1838–1851
Publication date
25 May 2026
Language
EN